Option Care Health, Inc. $OPCH Shares Sold by Gabelli Funds LLC

Key Points

• Gabelli Funds LLC reduced its stake in Option Care Health by 14% during the first quarter, selling 78,800 shares, leaving them with 484,300 shares valued at approximately $16.93 million.
• Insider trading saw Director Timothy P. Sullivan purchasing 20,000 shares at $27.51 each, which increased his ownership by 68.43%, while Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares at $27.15 each, a 10.61% increase in ownership.
• Option Care Health's recent earnings report showed an EPS of $0.41, exceeding analysts' expectations, with revenues of $1.42 billion, marking a 15.4% increase year-over-year.

Gabelli Funds LLC cut its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 14.0% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 484,300 shares of the company's stock after selling 78,800 shares during the quarter. Gabelli Funds LLC owned 0.30% of Option Care Health worth $16,926,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Teca Partners LP acquired a new position in Option Care Health during the first quarter worth $13,461,000. Walleye Trading LLC increased its position in Option Care Health by 19.0% during the first quarter. Walleye Trading LLC now owns 30,915 shares of the company's stock worth $1,080,000 after buying an additional 4,946 shares in the last quarter. Walleye Capital LLC purchased a new position in Option Care Health during the first quarter worth $6,264,000. Axiom Investors LLC DE increased its position in Option Care Health by 111.2% during the first quarter. Axiom Investors LLC DE now owns 361,615 shares of the company's stock worth $12,638,000 after buying an additional 190,417 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. increased its position in Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after buying an additional 836 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Option Care Health news, Director Timothy P. Sullivan acquired 20,000 shares of the stock in a transaction dated Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the transaction, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the stock in a transaction dated Wednesday, August 20th. The stock was acquired at an average cost of $27.15 per share, with a total value of $977,400.00. Following the transaction, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.64% of the stock is owned by insiders.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $27.92 on Wednesday. The company has a market cap of $4.53 billion, a P/E ratio of 22.34, a P/E/G ratio of 1.71 and a beta of 0.79. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The business has a fifty day simple moving average of $29.77 and a 200-day simple moving average of $31.71.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business's revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Wall Street Analyst Weigh In

OPCH has been the subject of several recent research reports. Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Barrington Research reissued an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. Finally, JMP Securities raised their price target on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Eight equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.